FMR CORP 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-10 10:33 am Sale |
2021-08-09 | 13G | Neurocrine Biosciences, Inc. NBIX |
FMR CORP | 3,780,076 3.994% |
-4,656,553 (-55.19%) |
Filing |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | Neurocrine Biosciences, Inc. NBIX |
FMR CORP | 8,436,629 9.022% |
1,005,256 (+13.53%) |
Filing |